Literature DB >> 11122329

Endogenous BDNF is required for myelination and regeneration of injured sciatic nerve in rodents.

J Y Zhang1, X G Luo, C J Xian, Z H Liu, X F Zhou.   

Abstract

Following a peripheral nerve injury, brain-derived neurotrophic factor (BDNF) and the p75 neurotrophin receptor are upregulated in Schwann cells of the Wallerian degenerating nerves. However, it is not known whether the endogenous BDNF is critical for the functions of Schwann cells and regeneration of injured nerve. Treatment with BDNF antibody was shown to retard the length of the regenerated nerve from injury site by 24%. Histological and ultrastructural examination showed that the number and density of myelinated axons in the distal side of the lesion in the antibody-treated mice was reduced by 83%. In the BDNF antibody-treated animals, there were only distorted and disorganized myelinated fibres in the injured nerve where abnormal Schwann cells and phagocytes were present. As a result of nerve degeneration in BDNF antibody-treated animals, subcellular organelles, such as mitochondria, disappeared or were disorganized and the laminal layers of the myelin sheath were loosened, separated or collapsed. Our in situ hybridization revealed that BDNF mRNA was expressed in Schwann cells in the distal segment of lesioned nerve and in the denervated muscle fibres. These results indicate that Schwann cells and muscle fibres may contribute to the sources of BDNF during regeneration and that the deprivation of endogenous BDNF results in an impairment in regeneration and myelination of regenerating axons. It is concluded that endogenous BDNF is required for peripheral nerve regeneration and remyelination after injury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122329

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  79 in total

1.  In vivo analysis of Schwann cell programmed cell death in the embryonic chick: regulation by axons and glial growth factor.

Authors:  Adam K Winseck; Jordi Caldero; Dolors Ciutat; David Prevette; Sheryl A Scott; Gouying Wang; Josep E Esquerda; Ronald W Oppenheim
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

Review 2.  Progesterone treatment of spinal cord injury: Effects on receptors, neurotrophins, and myelination.

Authors:  Alejandro F De Nicola; Susana L Gonzalez; Florencia Labombarda; Maria Claudia González Deniselle; Laura Garay; Rachida Guennoun; Michael Schumacher
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 3.  Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury.

Authors:  J Gordon Boyd; Tessa Gordon
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

4.  Exercise attenuates age-associated changes in motoneuron number, nucleocytoplasmic transport proteins and neuromuscular health.

Authors:  Ashley Gillon; Kathrine Nielsen; Charlotte Steel; Jon Cornwall; Philip Sheard
Journal:  Geroscience       Date:  2018-05-07       Impact factor: 7.713

Review 5.  Bioengineered nerve regeneration and muscle reinnervation.

Authors:  Paul J Kingham; Giorgio Terenghi
Journal:  J Anat       Date:  2006-10       Impact factor: 2.610

6.  The effects of potential neuroprotective agents on rat facial function recovery following facial nerve injury.

Authors:  Kalpesh T Vakharia; Robin W Lindsay; Christopher Knox; Colin Edwards; Doug Henstrom; Julie Weinberg; Tessa A Hadlock; James T Heaton
Journal:  Otolaryngol Head Neck Surg       Date:  2011-01       Impact factor: 3.497

7.  Electrical stimulation promotes peripheral axon regeneration by enhanced neuronal neurotrophin signaling.

Authors:  Arthur W English; Gail Schwartz; William Meador; Manning J Sabatier; Amanda Mulligan
Journal:  Dev Neurobiol       Date:  2007-02-01       Impact factor: 3.964

8.  Small-molecule trkB agonists promote axon regeneration in cut peripheral nerves.

Authors:  Arthur W English; Kevin Liu; Jennifer M Nicolini; Amanda M Mulligan; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

9.  HDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammation.

Authors:  Hyeon Ju Kim; De-Maw Chuang
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

10.  Fabrication of growth factor- and extracellular matrix-loaded, gelatin-based scaffolds and their biocompatibility with Schwann cells and dorsal root ganglia.

Authors:  Rodolfo E Gámez Sazo; Katsumi Maenaka; Weiyong Gu; Patrick M Wood; Mary Bartlett Bunge
Journal:  Biomaterials       Date:  2012-08-17       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.